SKI Market

Indian Indices

Sensex

80,238.85 -1,048.34
( -1.29%)

Global Indices

Nasdaq

48,521.56 -404.23
(-0.83%)

Dow Jones

6,836.74 -65.88
(-0.95%)

Hang Seng

56,282.78 -1,774.46
(-3.06%)

Nikkei 225

10,473.49 -306.62
(-2.84%)

Forex

USD-INR

91.06 0.13
(0.14%)

EUR-INR

107.55 0.22
(0.20%)

GBP-INR

122.70 -0.27
(-0.22%)

JPY-INR

0.58 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Shree Ganesh Biotech India Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

539470

INE051N01026

1.5954132

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

24.32

EPS(TTM)

Face Value()

Div & Yield %

Back

Kopran reports consolidated net loss of Rs 9.92 crore in the September 2025 quarter

Nov 12,2025

Net loss of Kopran reported to Rs 9.92 crore in the quarter ended September 2025 as against net profit of Rs 7.38 crore during the previous quarter ended September 2024. Sales declined 22.20% to Rs 117.91 crore in the quarter ended September 2025 as against Rs 151.56 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	117.91	151.56	-22
OPM %	-4.48	9.72	-
PBDT	-7.34	13.50	PL
PBT	-11.63	9.64	PL
NP	-9.92	7.38	PL

80,238.85 -1,048.34 ( -1.29%)

48,521.56 -404.23 (-0.83%)

6,836.74 -65.88 (-0.95%)

56,282.78 -1,774.46 (-3.06%)

10,473.49 -306.62 (-2.84%)

91.06 0.13 (0.14%)

107.55 0.22 (0.20%)

122.70 -0.27 (-0.22%)

0.58 0.00 (0.12%)